ANNE-MARIE ADDLETON: Open Payments
NPI 1912623646 · EVANS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,451 in 120 payments from 20 companies in 2025. Trend: 2023 $2,176 · 2024 $2,248 · 2025 $2,451
Food & beverage: $2,451
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 23 | $421 |
| Lilly USA, LLC | 18 | $324 |
| Amgen Inc. | 16 | $314 |
| Corcept Therapeutics | 10 | $253 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $143 |
| SANOFI-AVENTIS U.S. LLC | 5 | $134 |
| Ascendis Pharma Endocrinology Inc | 6 | $117 |
| Tandem Diabetes Care, Inc. | 5 | $116 |
| IBSA Pharma Inc. | 4 | $91 |
| Madrigal Pharmaceuticals | 3 | $87 |
Products named: Ozempic, MOUNJARO, Korlym, TEPEZZA, Kerendia, TZIELD, t:slim X2 Insulin Pump with Control-IQ, Yorvipath.
Industry payments across GA — which companies pay providers there.
